As TP53 mutations are relatively rare (<10%) in EW30, we compared gene sequences of the patient’s sample and of the PDX, because TP53 alterations can arise during the adaptation to in vitro culture of human sarcoma cells, resulting in a much higher proportion of cell lines harboring TP53 mutations than actual human tumors31. The gene discussed is TP53; the disease is sarcoma.